Sarah Vos - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Sarah Vos's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Sarah Vos
Verified
Blogger, Kentucky Health News
Kentucky, Lexington
Beats
Content
Advanced Glycation End Products Upregulate CD40 in Human Retinal Endothelial and Müller Cells: Relevance to Diabetic Retinopathy
By Jose-Andres C. Portillo, Sarah Vos, Amelia Pfaff, Matthew Weng| MDPI@ All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
By Sarah Vos, Dan Wolff| No Depression Verified EDITOR’S NOTE: Dead Horses are No Depression’s Spotlight band for September. Learn more about their new album, Brady Street, in our interview. Below, we asked core duo Sarah Vos (guitars, vocals, and songwriting) and Dan Wolff (bass) to write an essay shedding light on their personal side, and they each submitted their thoughts. I am delighted that No Depression asked us to write an essay on whatever topic we wish.
Advanced Glycation End Products Upregulate CD40 in Human Retinal Endothelial and Müller Cells: Relevance to Diabetic Retinopathy
By Jose-Andres C. Portillo, Sarah Vos, Amelia Pfaff, Matthew Weng| MDPI@ All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
Company Info